Isosource

Products

Isosource

Reliable Core Nutrition

The Isosource family is composed of nutritionally complete formulas intended for the dietary management of undernourished patients or those at risk of malnutrition.

Isosource products are composed of various standard formulas with different characteristics to allow you to choose a formula that best meets your patient’s specific requirements

  • These include varied energy distribution, amount of protein, and presence of fiber and/or natural ingredients

Isosource products provide balanced nutrition containing all the essential nutrients for a complete daily feeding, with a specific composition to also improve health and/or clinical conditions.

  • Core solutions to meet the fundamental nutritional needs of the widest possible range of your more stable patients, from short- to long-term care, and from hospital to home
  • Developed with high quality ingredients to provide a wide choice of macronutrient combinations
  • This means minimal disruption for patients and less need for nutritional re-evaluation

Isosource Adult Enteral Nutrition:

A reliable + flexible partner for short- and long-term stages of patient recovery.

Benefits of macronutrient combinations

  • Formulated with MCT, omega-6 and omega-3 fatty acids (including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and high quality protein to support patient health
  • The Isosource family protein blend is generally made up of casein, a high quality protein
    • Some Isosource family products may contain soy protein or blends of soy/milk protein
  • Essential amino acid requirements fulfilled with a complete feeding
    • Adapt the amount provided and chose the most appropriate Isosource family product to meet the individual requirements of patients

Isosource is comprehensively powered by science

EPA / DHA

Supports healthy cardiovascular and blood pressure maintenance with long term use

  • 500 mg of EPA + DHA /1500 kcal complete daily feeding

MCTs

Easily absorbed, providing a rapid source of energy

  • Contains at least 20% MCT

Omega-6 Omega-3

Within World Health Organisation recommendations

  • Provides 3-6% total energy of omega-6, 1-2% of omega-3

Linoleic acid

Reduces levels of low-density lipoproteins and increases the higher density lipoproteins

  • Generally contains 4-6 – 6.8% E2 linoleic acid

Fibre

  • Fibre-containing formulas within the Isosource range are formulated with a blend composed of 50:50% soluble and insoluble fibres
  • This ratio was chosen to provide efficacious dose of prebiotic fibres and to optimise GI tolerance and technical performance
  • The soluble component of the fibre blend includes fructo-oligosaccharide/inulin and acacia gum, while the insoluble portion is composed of outer pea fibre
  • Micronutrients (vitamins, minerals, trace elements) are essential to maintain normal health (inadequate supply can trigger unwanted clinical conditions)
    • The European recipe delivers all micronutrients within recommended ranges

Isosource products can also provide:

  • High energy concentration for patients with increased energy requirements and/ or fluid restriction
  • High protein concentration specifically for patients with increased protein needs
  • A 50:50 ratio of soluble and insoluble fibres
  • Prebiotics (acacia gum, inulin) to help improve gut health and reinforce immune protection during feeding and illness
  • The Isosource family contain raw materials derived from gluten-free sources
  • The Isosource family may be used to fulfill adult protein needs, according to the FAO/WHO 2007, ESPEN 2006 for geriatrics and DRI 2002/2005 recommendations1-3

1. DRI (2002/2005). Dietary Reference Intakes for Energy, Carbohydrate, Fibre, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids. Food and Nutrition Board, Institute of Medicine, National Academy of Science. 2. Volkert D, et al. Clin Nutr 2006;25(2):330-360. 3. FAO/WHO (2007). Protein and amino acid requirements in human nutrition: report of a joint FAO/WHO/UNU expert consultation. WHO technical report series no935.